Richard St. Francis

SVP and Head of Finance


“We have a unique opportunity with genomics and deep phenotyping to make a difference in someone’s daily health.”

Rich St. Francis, CPA, brings over 25 years of experience as a finance executive across both established and emerging markets in Pharmaceuticals, Vaccines, Diagnostics, and CROs.

Prior to Genuity Science, Rich was CVP, FP&A and Chief Accounting Officer at Paraxel. He brings significant global Commercial, Research, Development and Technical Development experience in both established and emerging markets in Pharmaceuticals, Vaccines, Diagnostics and CROs as well as experience in highly matrixed global organizations.

Rich holds a bachelor’s degree in Marketing from Bentley University and a MS in Accounting from Southern New Hampshire University.